Stay updated on Pediatric Fremanezumab for Episodic Migraine Clinical Trial
Sign up to get notified when there's something new on the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page.

Latest updates to the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedRevision: v3.3.3 was added to the record history. The HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry were removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision history shows an addition of v3.3.2 and removal of v3.2.0 in the page footer, reflecting a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedRemoved the government funding operating status notice from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check59 days agoChange DetectedNew versions show updates to the study status and related sections such as recruitment and Contacts/Locations. These changes reflect ongoing updates to the trial record.SummaryDifference0.0%

- Check88 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference8%

- Check95 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.2%

Stay in the know with updates to Pediatric Fremanezumab for Episodic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page.